• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在第一次和第二次全国健康与营养检查调查(NHANES I和NHANES II)随访研究中,男性体重指数和肥胖与全因死亡率的差异关联。

Differential associations of body mass index and adiposity with all-cause mortality among men in the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II) follow-up studies.

作者信息

Allison D B, Zhu S K, Plankey M, Faith M S, Heo M

机构信息

Department of Biostatistics and Clinical Nutrition Research Center, University of Alabama at Birmingham, Birmingham, Alabama 35294-0022, USA.

出版信息

Int J Obes Relat Metab Disord. 2002 Mar;26(3):410-6. doi: 10.1038/sj.ijo.0801925.

DOI:10.1038/sj.ijo.0801925
PMID:11896498
Abstract

OBJECTIVE

The frequently observed U-shaped relationship between body mass index (BMI; kg/m(2)) and mortality rate may be due to the opposing effects of fat mass (FM) and fat-free mass (FFM) components of BMI on mortality rate. The purpose is to test the hypothesis stated above.

DESIGN

Longitudinal prospective cohort studies. The mortality follow-up of the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II).

SUBJECTS

A total of 10 169 male subjects aged 25-75 who participated in NHANES I and II were selected for analyses. Follow-up continued until 1992. The mean follow-up time was 14.6 y for NHANES I and 12.9 y for NHANES II. Ninety-eight percent of the participants were successfully followed representing a total of 3722 deaths.

MEASUREMENTS

Subscapular and triceps skinfolds thickness were used as FM indicators, whereas upper arm circumference was used as a FFM indicator. The Cox proportional hazards model tested the relationships of BMI, FM and FFM with all-cause mortality adjusting for age, smoking status, race and education levels.

RESULTS

BMI had a U-shaped relationship with mortality, with a nadir of approximately 27 kg/m(2). However, when indicators of FM and FFM were added to the model, the relationship between BMI and mortality became more nearly monotonic increasing. Moreover, the relationship between FM indicator and mortality was monotonic increasing and the relationship between FFM indicator and mortality was monotonic decreasing.

CONCLUSION

These results support the hypothesis that the apparently deleterious effects of marked thinness may be due to low FFM and that, over the observed range of the data, marked leanness (as opposed to thinness) has beneficial effects.

摘要

目的

体重指数(BMI;千克/米²)与死亡率之间常见的U型关系可能归因于BMI中脂肪量(FM)和去脂体重(FFM)成分对死亡率的相反影响。目的是检验上述假设。

设计

纵向前瞻性队列研究。对第一次和第二次全国健康与营养检查调查(NHANES I和NHANES II)进行死亡率随访。

研究对象

共选取10169名年龄在25 - 75岁之间、参与NHANES I和II的男性受试者进行分析。随访持续至1992年。NHANES I的平均随访时间为14.6年,NHANES II为12.9年。98%的参与者成功随访,共3722例死亡。

测量指标

肩胛下和肱三头肌皮褶厚度用作FM指标,而上臂围用作FFM指标。Cox比例风险模型检验了BMI、FM和FFM与全因死亡率之间的关系,并对年龄、吸烟状况、种族和教育水平进行了校正。

结果

BMI与死亡率呈U型关系,最低点约为27千克/米²。然而,当将FM和FFM指标加入模型后,BMI与死亡率之间的关系变得更接近单调递增。此外,FM指标与死亡率之间的关系是单调递增的,FFM指标与死亡率之间的关系是单调递减的。

结论

这些结果支持以下假设,即明显消瘦的有害影响可能归因于低FFM,并且在观察到的数据范围内,显著的瘦(与消瘦相对)具有有益影响。

相似文献

1
Differential associations of body mass index and adiposity with all-cause mortality among men in the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II) follow-up studies.在第一次和第二次全国健康与营养检查调查(NHANES I和NHANES II)随访研究中,男性体重指数和肥胖与全因死亡率的差异关联。
Int J Obes Relat Metab Disord. 2002 Mar;26(3):410-6. doi: 10.1038/sj.ijo.0801925.
2
Associations of body mass index and anthropometric indicators of fat mass and fat free mass with all-cause mortality among women in the first and second National Health and Nutrition Examination Surveys follow-up studies.在第一次和第二次全国健康与营养检查调查随访研究中,体重指数以及脂肪量和去脂体重的人体测量指标与女性全因死亡率之间的关联。
Ann Epidemiol. 2003 Apr;13(4):286-93. doi: 10.1016/s1047-2797(02)00417-9.
3
Adiposity, adipose tissue distribution and mortality rates in the Canada Fitness Survey follow-up study.加拿大健身调查随访研究中的肥胖、脂肪组织分布与死亡率
Int J Obes Relat Metab Disord. 2002 Aug;26(8):1054-9. doi: 10.1038/sj.ijo.0802057.
4
Body composition unaltered for African women classified as 'normal but vulnerable' by body mass index and mid-upper-arm-circumference criteria.根据体重指数和上臂中部周长标准被归类为“正常但脆弱”的非洲女性,其身体组成未发生改变。
Eur J Clin Nutr. 2001 May;55(5):393-9. doi: 10.1038/sj.ejcn.1601171.
5
Biases in the mortality risk versus body mass index relationship in the NHANES-1 Epidemiologic Follow-Up Study.美国国家健康和营养检查调查第一轮流行病学随访研究中死亡率风险与体重指数关系的偏差
Int J Obes Relat Metab Disord. 2001 Jul;25(7):1071-8. doi: 10.1038/sj.ijo.0801648.
6
Body fat and fat-free mass and all-cause mortality.体脂、去脂体重与全因死亡率
Obes Res. 2004 Jul;12(7):1042-9. doi: 10.1038/oby.2004.131.
7
Effects of HIV infection on body composition changes among men of different racial/ethnic origins.人类免疫缺陷病毒(HIV)感染对不同种族/族裔男性身体成分变化的影响。
HIV Clin Trials. 2007 May-Jun;8(3):145-54. doi: 10.1310/hct0803-145.
8
Comparison of fat-free mass and body fat in Swiss and American adults.瑞士和美国成年人瘦体重与体脂的比较。
Nutrition. 2005 Feb;21(2):161-9. doi: 10.1016/j.nut.2004.04.023.
9
Fat mass to fat-free mass ratio reference values from NHANES III using bioelectrical impedance analysis.用生物电阻抗分析法从 NHANES III 得出体脂肪量与去脂体重比值参考值。
Clin Nutr. 2018 Dec;37(6 Pt A):2284-2287. doi: 10.1016/j.clnu.2017.09.021. Epub 2017 Oct 6.
10
[Assessment of body composition in groups of subjects with different body size. Comparison of skinfold thickness and impedance methods].[不同体型受试者群体的身体成分评估。皮褶厚度法与阻抗法的比较]
Ann Ital Med Int. 1994 Oct-Dec;9(4):223-7.

引用本文的文献

1
Investigating the relationship between body roundness index and low muscle mass based on a cross-sectional study: Focus on visceral adipose tissue.基于横断面研究探讨身体圆润度指数与低肌肉量之间的关系:关注内脏脂肪组织。
PLoS One. 2025 Aug 19;20(8):e0326441. doi: 10.1371/journal.pone.0326441. eCollection 2025.
2
Assessing Metabolic Syndrome Risk in Children and Adolescents with Prader-Willi Syndrome: A Comparison of Index Performance.评估普拉德-威利综合征患儿和青少年的代谢综合征风险:指标性能比较
J Clin Med. 2025 Jul 3;14(13):4716. doi: 10.3390/jcm14134716.
3
Association of relative fat mass (RFM) index with diabetes-related mortality and heart disease mortality.
相对脂肪量(RFM)指数与糖尿病相关死亡率和心脏病死亡率的关联。
Sci Rep. 2024 Dec 28;14(1):30823. doi: 10.1038/s41598-024-81497-6.
4
Association between physical activity levels and mortality across adiposity: A longitudinal study of age-specific Asian populations.身体活动水平与肥胖程度相关的死亡率之间的关联:特定年龄段亚洲人群的纵向研究。
Geriatr Gerontol Int. 2024 Nov;24(11):1156-1164. doi: 10.1111/ggi.14987. Epub 2024 Oct 2.
5
Discriminating factors of body composition characteristics for academic performance in nursing college students: a cross-sectional study.护理专业大学生学业成绩的身体成分特征鉴别因素:一项横断面研究。
BMC Nurs. 2024 May 3;23(1):305. doi: 10.1186/s12912-024-01969-y.
6
Temporal trends in obesity defined by the relative fat mass (RFM) index among adults in the United States from 1999 to 2020: a population-based study.1999 年至 2020 年美国成年人相对脂肪质量(RFM)指数定义的肥胖的时间趋势:一项基于人群的研究。
BMJ Open. 2023 Aug 17;13(8):e071295. doi: 10.1136/bmjopen-2022-071295.
7
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management.肌少症性肥胖:流行病学、病理生理学、心血管疾病、死亡率和管理。
Front Endocrinol (Lausanne). 2023 Jun 30;14:1185221. doi: 10.3389/fendo.2023.1185221. eCollection 2023.
8
Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors.癌症幸存者全身脂肪量和骨骼肌指数与全因死亡率及癌症特异性死亡率的关联。
Cancers (Basel). 2023 Feb 8;15(4):1081. doi: 10.3390/cancers15041081.
9
Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta-analysis.肌肉减少症在肾移植受者中的诊断、患病率和结局:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):17-29. doi: 10.1002/jcsm.13130. Epub 2022 Nov 20.
10
Lifestyle Strategies for the Management of Obesity in Older Adults: From Controversies to Alternative Interventions.老年人肥胖管理的生活方式策略:从争议到替代干预措施
Healthcare (Basel). 2022 Oct 21;10(10):2107. doi: 10.3390/healthcare10102107.